Colorectal Cancer Awareness Month
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 21 June 2024 | Viewed by 163
Special Issue Editor
Special Issue Information
Dear Colleagues,
Globally, colorectal cancer is the third most diagnosed cancer and ranks second in cancer-related deaths overall. Its screening and early detection have led to improvements in the survival of patients, especially those with early-stage disease; however, for patients who are diagnosed with unresectable metastatic colorectal cancer, the outlook remains grim. In the past decade, developments in targeted therapies have improved patient survival, but the benefits are still modest. While immunotherapies have been shown to be effective and result in durable responses in a subset of patients, effective therapies for the majority of patients are still required. Additionally, increases in patients with early onset colorectal cancer present an area of major concern. The roles of liquid biopsies, targeted drug therapies, immunotherapies, and less- as well as non-invasive treatments are some of the evolving horizons in managing and combating this terrible disease.
March is designated as "World Colorectal Cancer Awareness Month", with various global activities to highlight the importance of screening for colorectal cancer and increasing awareness of colorectal cancer for research support and development.
We would like to take this opportunity to appreciate all of the researchers who have contributed to the fight against this disease. In particular, we would like to highlight several topics in this field, which cover early detection, promising therapeutic targets, new therapeutic strategies, the biology of colorectal tumors, and early onset colorectal cancer. We hope that this Special Issue will provide useful information for both basic and translational researchers and help improve clinical practice.
Dr. Rajat Bhattacharya
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer
- screening
- early detection
- therapeutic targets
- therapeutic strategies
- early onset colorectal cancer
